| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 05/02/1996 | WO1996012808A1 Nucleic acid preparation for immunization and method for immunization using the same |
| 05/02/1996 | WO1996012807A2 Hepatitis e virus antigens and uses therefor |
| 05/02/1996 | WO1996012802A1 Vaccine and antitoxin for treatment and prevention of c. difficile disease |
| 05/02/1996 | WO1996012801A1 Oral immunization with transgenic plants |
| 05/02/1996 | WO1996012799A1 Neutralization of foof allergens by thioredoxin |
| 05/02/1996 | WO1996012794A2 Isolated porcine pancreatic cells for use in treatment of diseases characterized by insufficient insulin activity |
| 05/02/1996 | WO1996012742A1 Binding agents for treatment of inflammatory, autoimmune or allergic diseases |
| 05/02/1996 | WO1996012741A1 Binding agents to cd23 |
| 05/02/1996 | WO1996012740A1 SYNTHETIC IgE MEMBRANE ANCHOR PEPTIDE IMMUNOGENS FOR THE TREATMENT OF ALLERGY |
| 05/02/1996 | WO1996012737A2 Compositions and treatment for multiple sclerosis |
| 05/02/1996 | WO1996012734A1 Vaccine preparation recovered from bacteria grown in iron-rich media |
| 05/02/1996 | WO1996012733A1 Major outer membrane protein cd of moraxella |
| 05/02/1996 | WO1996012503A1 Remedy for diseases caused by il-6 production |
| 05/02/1996 | WO1996012502A1 Method of culturing m. bovis in low available iron media and production of infectious bovine keratoconjunctivitis vaccine therefrom |
| 05/02/1996 | WO1996012501A1 Human hypoxanthine-(guanine) phosphoribosyl transferase-2 |
| 05/02/1996 | WO1996012475A1 Active agent transport systems |
| 05/02/1996 | WO1996012474A1 Compositions for the delivery of antigens |
| 05/02/1996 | WO1996012473A1 Compounds and compositions for delivering active agents |
| 05/02/1996 | WO1996004011A3 Novel compound to mimic a naturally occurring peptide's effect |
| 05/02/1996 | CA2652992A1 Nucleotide sequences of hiv-1 type (or subtype) o retrovirus antigens |
| 05/02/1996 | CA2416318A1 Soluble, recombinant botulinum toxin proteins |
| 05/02/1996 | CA2203629A1 Compositions and treatment for multiple sclerosis |
| 05/02/1996 | CA2203504A1 Vaccine and antitoxin for treatment and prevention of c. difficile disease |
| 05/02/1996 | CA2203364A1 Binding agents for treatment of inflammatory, autoimmune or allergic diseases |
| 05/02/1996 | CA2203363A1 Binding agents to cd23 |
| 05/02/1996 | CA2203165A1 Synthetic ige membrane anchor peptide immunogens for the treatment of allergy |
| 05/02/1996 | CA2203105A1 Hippocampus-associated proteins, dna sequences coding therefor and uses thereof |
| 05/02/1996 | CA2202299A1 Compositions for the delivery of antigens |
| 05/01/1996 | EP0709460A1 Coccidiosis poultry vaccine |
| 05/01/1996 | EP0709397A1 p53as Protein and antibody therefor |
| 05/01/1996 | EP0709396A1 Gamma T cell receptor and methods for detection |
| 05/01/1996 | EP0709097A1 Anti-Fas antibody for rheumatic disease |
| 05/01/1996 | EP0708923A1 Recombinant 170 kd subunit lectin of entamoeba histolytica and methods of use |
| 05/01/1996 | EP0708832A1 Helicobacter pylori haemagglutinin/protease protein, nucleic acid encoding therefor and antibodies specific thereto |
| 05/01/1996 | EP0708767A1 Haptens, tracers, immunogens and antibodies for carbazole and dibenzofuran derivatives |
| 05/01/1996 | EP0708661A1 Transferrin receptor specific ligand-neuropharmaceutical agent fusion proteins |
| 05/01/1996 | EP0708659A1 Hiv envelope polypeptides |
| 05/01/1996 | EP0708658A1 Recombinant cytomegalovirus vaccine |
| 05/01/1996 | EP0708656A1 Immunogenic lhrh peptide constructs and synthetic universal immune stimulators for vaccines |
| 05/01/1996 | EP0708592A1 Mts gene, mutations therein, and methods for diagnosing cancer using mts gene sequence |
| 05/01/1996 | EP0542845B1 Plasmodium falciparum antigen for eliciting protective antibodies for use in vaccines |
| 05/01/1996 | EP0491031B1 Cdr grafted anti-cea antibodies and their production |
| 05/01/1996 | EP0441917B1 Pokeweed antiviral protein - monoclonal antibody conjugates |
| 05/01/1996 | CN1121725A Immunoparticles bearing monoclonal anti-CD4 antibodies and utilisation thereof |
| 05/01/1996 | CN1121724A Extraction of cell-bound protein from bordetella |
| 05/01/1996 | CN1121430A Inmunization adjusting, anti-inflamation agent |
| 04/30/1996 | US5512675 Methods for preparing porphyrin-like compounds |
| 04/30/1996 | US5512660 Purified ICAM-2 and fragment thereof |
| 04/30/1996 | US5512658 Pseudomonas exotoxins (PE) and conjugates thereof having lower animal toxicity with high cytocidal activity through substitution of positively charged amino acids |
| 04/30/1996 | US5512455 Atrial natriuretic peptide receptor protein |
| 04/30/1996 | US5512443 Second generation monoclonal antibodies having binding specificity to TAG-72 and human carcinomas and methods for employing the same |
| 04/30/1996 | US5512288 Administering culture product from medium containing bile |
| 04/30/1996 | US5512286 Extract from leaves of ginkgo biloba for intravenous injection or infusion |
| 04/30/1996 | US5512283 Methods for the selective suppression of an immune response to dust mite der Pi |
| 04/25/1996 | WO1996012190A2 Presentation of hydrophobic antigens to t-cells by cd1 molecules |
| 04/25/1996 | WO1996012184A1 Diagnosis and monitoring process, and medicaments for the therapy of states of shock in human beings |
| 04/25/1996 | WO1996012024A1 Cloning, expression and characterisation of a novel form of phosphatidylinositol-3-kinase |
| 04/25/1996 | WO1996012020A2 Hemoglobin receptors from neisseriae |
| 04/25/1996 | WO1996012009A2 Methods for engineering antigen-presenting cells |
| 04/25/1996 | WO1996011946A1 Human endothelin-bombesin receptor |
| 04/25/1996 | WO1996011944A1 Synthetic peptides and vaccines comprising same |
| 04/25/1996 | WO1996011709A1 Synthesis of typhoid fever vaccine from a plant or fruit polysaccharide |
| 04/25/1996 | WO1996011708A1 Membrane expression of heterologous genes |
| 04/25/1996 | WO1996011707A1 Renibacterium salmoninarum vaccine and method for its preparation |
| 04/25/1996 | WO1996011706A1 Use of flea proteases and protease inhibitors to protect animals from flea infestation |
| 04/25/1996 | WO1996011664A2 Nsk2 a muscle receptor tyrosine kinase |
| 04/25/1996 | CA2203116A1 Hemoglobin receptors from neisseriae |
| 04/25/1996 | CA2202680A1 Presentation of hydrophobic antigens to t-cells by cd1 molecules |
| 04/25/1996 | CA2202622A1 Use of protease inhibitors and protease vaccines to protect animals from flea infestation, and flea protease proteins, nucleic acid molecules and uses thereof |
| 04/25/1996 | CA2202465A1 Process for the diagnostic assessment and monitoring, as well as medicaments for the therapy of states of shock in humans |
| 04/24/1996 | EP0707652A1 Dna coding for a peptide of a papilloma virus main capside protein and use thereof |
| 04/24/1996 | EP0707651A1 METHODS AND COMPOSITIONS FOR DETECTION OF $i(SALMONELLA) |
| 04/24/1996 | EP0707649A1 Cisplatin resistance gene and uses therefor |
| 04/24/1996 | EP0707648A1 Platelet glycoprotein v gene and uses |
| 04/24/1996 | EP0707597A1 ANTIGENIC POLYPEPTIDES OF $i(T. OVIS) AND VACCINES CONTAINING SUCH POLYPEPTIDES |
| 04/24/1996 | EP0707496A1 METHODS AND COMPOSITIONS FOR DETECTING AND TREATING MYCOBACTERIAL INFECTIONS USING AN inhA GENE |
| 04/24/1996 | EP0707494A1 Bloody swine dysentery vaccine and vaccination kit therefor |
| 04/24/1996 | EP0707493A1 Inhibitors and target molecule co-localization |
| 04/24/1996 | EP0707485A1 Anti-cholesterolemic egg, vaccine and method for production, and use |
| 04/24/1996 | EP0707471A1 Novel therapeutic drug delivery systems |
| 04/24/1996 | EP0380542B1 Method for treating malignancy and autoimmune disorders in humans |
| 04/24/1996 | CN1121357A Hepatitis B escape mutant specific binding molecules |
| 04/24/1996 | CN1121312A Chlamydia vaccine and process |
| 04/23/1996 | US5510466 Scavenger receptor protein and antibody thereto |
| 04/23/1996 | US5510465 Generating non-specific complement activation in reduced amount in an in vitro assay while being capable of retaining antigen binding and specific complement activating activity |
| 04/23/1996 | US5510330 Combinations of thrombolytically active proteins and non-heparin anticoagulants, and uses thereof. |
| 04/23/1996 | US5510264 Antibodies which bind meningitis related homologous antigenic sequences |
| 04/23/1996 | US5510263 Growth of pancreatic islet-like cell clusters |
| 04/23/1996 | US5510259 Isolated, purified dna having nucleotide sequence coding for said molecule |
| 04/23/1996 | US5510258 Porcine reproductive and respiratory syndrome virus antigen and processes for the preparation and use of said antigen in vaccines and diagnostics |
| 04/23/1996 | US5510240 Method of screening a peptide library |
| 04/23/1996 | US5510106 Immunological response |
| 04/18/1996 | WO1996011279A2 Enhanced immune response by introduction of cytokine gene and/or costimulatory molecule b7 gene in a recombinant virus expressing system |
| 04/18/1996 | WO1996011274A1 Chimeric papillomavirus-like particles |
| 04/18/1996 | WO1996011273A1 Papillomavirus vaccine |
| 04/18/1996 | WO1996011272A2 Papilloma virus-like particles, fusion proteins and process for producing the same |
| 04/18/1996 | WO1996011271A1 Novel ectoparasite saliva proteins and apparatus to collect such proteins |
| 04/18/1996 | WO1996011269A2 Tie-2 ligands, methods of making and uses thereof |
| 04/18/1996 | WO1996011258A1 Methods for producing enhanced antigenic enteric bacteria and vaccines comprising same |
| 04/18/1996 | WO1996011257A1 Methods for producing enhanced antigenic helicobacter sp. and vaccines comprising same |